Urolithiasis Symposium Logo NIDDK 2006 Urolithiasis Symposium March 9-10, 2006 Wyndham Baltimore Inner Harbor Baltimore, MD
Home
Registration
Agenda
Local Area Information
Hotel Information
Meeting Location
Agenda

  Print This Page   
   
This agenda is available for download in PDF format.* Click Here to download a PDF version of this page.

For information about downloading and viewing PDF files, or to download the free Adobe Acrobat software, Click Here or scroll to the bottom of this page.

     
Thursday, March 9, 2006
     
7:55 a.m. - 8:00 a.m. Welcome Gary Curhan
     
8:00 a.m. - 10:00 a.m. Clinical Management Oral Session  
     
8:00 a.m. - 9:00 a.m. Medical Management of Stone Disease  
  Moderator: David S. Goldfarb  
 
Future of trials in urolithiasis Leroy Nyberg Jr. and John Kusek
New medications for stone prevention John Asplin
Physiologic issues in the clinical management of calcium phosphate stones Mitch Halperin
Management of stones in the pediatric population Craig Langman
Long-term stone prevention: adherence
and adverse effects of medications
David Goldfarb
Pharmacogenomics and the Prevention
of Stone Recurrence
Carla Monico
     
9:00 a.m. - 10:00 a.m. Surgical Management of Stone Disease
  Moderator: Martin Resnick  
 
Shokewave lithotripsy James Lingeman
Percutaneous nephrolithotomy Steven Nakada
Ureteroscopy John Denstedt
Laparoscopic approaches for renal and
ureteral calculi
Stuart Wolf
     
10:00 a.m. - 10:10 a.m. Comment Period for Clinical Management Session
     
10:10 a.m. - 10:30 a.m. Break  
     
10:30 a.m. - 11:45 a.m. Imaging
  Moderator: Dawn Milliner  
 
Preferred imaging modalities for stones Bruce McClennan
The future of stone imaging/New modalities to reduce radiation exposure Cynthia McCollough
Determination of stone composition and
fragility by imaging
James C. Williams, Jr.
     
11:45 a.m. - 11:55 a.m. Comment Period for Imaging Oral Session  
     
12:00 noon - 1:00 p.m. Lunch  
     
1:00 p.m. - 2:00 p.m. Critical Steps for Stone Formation
  Moderator: Michael D. Ward  
 
Earliest phases of stone formation Fred Coe
Biomineralization of Uric Acid Jennifer Swift
Mechanisms of action of relevant urinary inhibitors Jeff A. Wesson
Cellular response to oxalate challenges Julie Jonassen
     
2:00 p.m. - 2:10 p.m. Comment Period for Stone Structure/Crystal
Attachment Oral Session
     
2:10 p.m. - 3:40 p.m. Breakout Meetings * Moderator
 
Clinical management Martin Resnick and David S. Goldfarb
Imaging Dawn Milliner
Critical steps for stone formation Michael Ward
     
3:40 p.m. - 4:00 p.m. Break
     
4:00 p.m. - 5:15 p.m. Pathophysiology
  Moderator: Elaine Worcester  
 
Mechanisms of hypercalciuria Fred Coe
Uric acid and stone disease Khashayar Sakhaee
Obesity, bariatric surgery, and stone
disease
Elaine Worcester
Oxalate absorption and renal handling David Mount
Importance of citrate handling in stone disease Patricia Preisig
     
5:15 p.m. - 5:25 p.m. Comment Period for Pathophysiology
     
5:30 p.m. Adjourn
     
     
     
   Back to Top
     
     
     
Friday, March 10
     
7:30 a.m. - 8:30 a.m. Animal Models
  Moderator: John Lieske  
 
Models of hyperoxaluria: is any one preferred? Neil Mandel
What can models of hypercalciuria teach
us about human nephrolithiasis?
David Bushinsky
Other models of intrarenal crystal
deposition
Jay Tischfield
Newer genetic models of calcium stone
disease
Xue-Ru Wu
     
8:30 a.m. - 8:40 a.m. Comment Period
     
8:40 a.m. - 9:55 a.m. Genetics/Genomics/Proteomics Oral Session
  Moderator: Orson Moe  
 
Can transcriptional profiling help with understanding kidney stones? Matthias Kretzler
Should NIDDK have a core facility and database for nephrolithiasis research?
Erwin Bottinger
The potential role of urinary proteomics in nephrolithiasis John Arthur
Application of proteomics in renal tissue
from patients with nephrolithiasis
TBD
     
9:55 a.m. - 10:05 a.m. Comment Period for Genetics/Genomics/Proteomics Oral Session
     
10:05 a.m. - 11:50 a.m. Breakout Meetings * Moderator
 
Pathophysiology Elaine Worcester
Animal Models John Lieske
Genetics/genomics/proteomis Orson Moe
     
11:50 a.m. - 12:50 p.m. Presentation of Major Recommendations by Each Breakout Group
     
1:00 p.m. Adjourn
     
     
     

* The breakout sessions will not have posters or talks. The goal is to have a discussion about the issues that will be raised during the talks and by the breakout moderators. A written document will be prepared from each breakout session describing the recommendations for future research in the area.
     
     
     Back to Top
   
 
  * PDF files require the free Adobe Acrobat Reader for viewing. Attention vissually impared visitors: To use common screen reading programs with PDF documents, please visit http://access.adobe.com which provides free tools that convert PDF documents to simple HTML or ASCII text.
   

Return to NIDDK Homepage.
This page last updated on 2/16/2006.
DHHS, NIH, DHHS